In one survey of GLP-1 users, 58% failed to hit the 1.22.0 g/kg/day target (2025 joint advisory, ACLM/ASN/OMA/TOS)
People who have experienced tirzepatide diarrhea or tirzepatide constipation already know these side effects can be difficult to manage
Your label should be clear and include the peptide name, the concentration, and the date of reconstitution
The 0.25 mg dose is approximately one-tenth of the full therapeutic dose
Our physician-guided programs may include: advanced metabolic evaluation personalized weight loss strategies hormonal health optimization lifestyle and nutritional guidance medical weight management As research continues to evolve, therapies such as GLP-1 medications and next-generation metabolic drugs may play an increasingly important role in sustainable weight loss
Beyond the obesity indication, they are studying retatrutide for type 2 diabetes (TRIUMPH-2), obstructive sleep apnea (TRIUMPH-3), and cardiovascular outcomes
